Home/Pipeline/ND0612

ND0612

Parkinson's disease motor fluctuations

Phase 3Active

Key Facts

Indication
Parkinson's disease motor fluctuations
Phase
Phase 3
Status
Active
Company

About NeuroDerm

NeuroDerm creates a continuous subcutaneous levodopa/carbidopa infusion system for Parkinson’s disease motor fluctuations.

View full company profile

Therapeutic Areas